A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non–small-cell lung cancer: a 5-year follow-up report

This publication has 31 references indexed in Scilit:

• Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in rtog 88-08/ECOG 4588
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation therapy oncology group (RTOG) 92-04
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
  Journal of Clinical Oncology, 1995
• Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma
  Lung Cancer, 1994
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 Patients
  JNCI Journal of the National Cancer Institute, 1991
• A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1990
• Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group
  Cancer, 1987
• Cis‐dichlorodiammineplatinum (II) and VP 16–213 combination chemotherapy for non‐small cell lung cancer
  Medical and Pediatric Oncology, 1981